Anna Raciborska
Clinical trials sponsored by Anna Raciborska, explained in plain language.
-
New hope for kids with rare immune disorder after other treatments fail
Disease control Recruiting nowThis study aims to find the safest and most effective way to use the drug trametinib for children with a rare immune system disorder called histiocytosis. It is for kids whose disease has not responded to standard treatments or a previous targeted drug, and who do not have a spec…
Phase: PHASE2 • Sponsor: Anna Raciborska • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New scans and blood tests aim to sharpen fight against rare childhood disease
Knowledge-focused Recruiting nowThis study aims to improve how doctors diagnose and monitor a rare blood disorder called histiocytosis in children and teenagers. Researchers will test how well a special type of PET-CT scan works and analyze tumor tissue and blood samples to understand the disease better. The go…
Phase: PHASE3 • Sponsor: Anna Raciborska • Aim: Knowledge-focused
Last updated Apr 02, 2026 04:12 UTC